PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR OF SOFT TISSUES

Clinical trials for PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR OF SOFT TISSUES explained in plain language.

Never miss a new study

Get alerted when new PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR OF SOFT TISSUES trials appear

Sign up with your email to follow new studies for PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR OF SOFT TISSUES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New hope for rare bone cancer: major trial tests drug to stop tumor growth

Disease control Ongoing

This large, late-stage trial is testing if adding a new drug called ganitumab to standard chemotherapy helps patients with newly diagnosed Ewing sarcoma that has spread. Ganitumab is designed to block a pathway that helps tumor cells grow. The study aims to see if this combinatio…

Matched conditions: PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR OF SOFT TISSUES

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR OF SOFT TISSUES

Get alerted when new PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR OF SOFT TISSUES trials appear

New hope for rare bone cancer: major trial tests drug to stop tumor growth